Chapter 105 – Schizophrenia

作者: David W. Volk , David A. Lewis

DOI: 10.1016/B978-0-12-410529-4.00105-4

关键词:

摘要: Schizophrenia is a severe, chronic psychiatric illness characterized by delusions and hallucinations, negative ­symptoms, cognitive dysfunction that frequently leads to lifetime of impairment disability. appears be caused complicated interactions between heritable genetic risk factors range environmental exposures. Genome-wide association studies have identified common, rare, de novo structural mutations contribute the liability schizophrenia. Impairments in cortical subcortical circuitry, including ­disturbances multiple neurotransmitter systems, appear core components neurobiological basis Current treatments for schizophrenia include antipsychotic medications psychosocial ­interventions.

参考文章(58)
Oliver D. Howes, Joseph Kambeitz, Euitae Kim, Daniel Stahl, Mark Slifstein, Anissa Abi-Dargham, Shitij Kapur, The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment Archives of General Psychiatry. ,vol. 69, pp. 776- 786 ,(2012) , 10.1001/ARCHGENPSYCHIATRY.2012.169
Bin Xu, J Louw Roos, Shawn Levy, E J van Rensburg, Joseph A Gogos, Maria Karayiorgou, Strong association of de novo copy number mutations with sporadic schizophrenia. Nature Genetics. ,vol. 40, pp. 880- 885 ,(2008) , 10.1038/NG.162
Jill R Glausier, David A Lewis, Selective Pyramidal Cell Reduction of GABAA Receptor α1 Subunit Messenger RNA Expression in Schizophrenia Neuropsychopharmacology. ,vol. 36, pp. 2103- 2110 ,(2011) , 10.1038/NPP.2011.102
Nikolaos Mellios, Hsien-Sung Huang, Stephen P. Baker, Marzena Galdzicka, Edward Ginns, Schahram Akbarian, Molecular Determinants of Dysregulated GABAergic Gene Expression in the Prefrontal Cortex of Subjects with Schizophrenia Biological Psychiatry. ,vol. 65, pp. 1006- 1014 ,(2009) , 10.1016/J.BIOPSYCH.2008.11.019
R. Gil, C. D. D'Souza, J. Erdos, E. McCance, W. Rosenblatt, C. Fingado, S. S. Zoghbi, R. M. Baldwin, J. P. Seibyl, J. H. Krystal, D. S. Charney, R. B. Innis, M. Laruelle, A. Abi-Dargham, C. H. van Dyck, Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects Proceedings of the National Academy of Sciences of the United States of America. ,vol. 93, pp. 9235- 9240 ,(1996) , 10.1073/PNAS.93.17.9235
Michael F. Green, Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. The Journal of Clinical Psychiatry. ,vol. 67, pp. 3- 8 ,(2006) , 10.4088/JCP.1006E12
Detelina Grozeva, George Kirov, Donald F Conrad, Chris P Barnes, Matthew Hurles, Michael J Owen, Michael C O'Donovan, Nick Craddock, Reduced burden of very large and rare CNVs in bipolar affective disorder. Bipolar Disorders. ,vol. 15, pp. 893- 898 ,(2013) , 10.1111/BDI.12125
Patrick F. Sullivan, Mark J. Daly, Michael O'Donovan, Genetic Architectures of Psychiatric Disorders: The Emerging Picture and Its Implications Nature Reviews Genetics. ,vol. 13, pp. 537- 551 ,(2012) , 10.1038/NRG3240